Antitrust regulators can improve their performance by relying on responsible use of artificial intelligence tools.
Scholars evaluate proposed frameworks for regulating ChatGPT and other generative AI.
Scholars argue for the creation of a regulatory safe space to supplement AI regulations.
Scholar argues that Congress and FDA should treat risky clinical artificial intelligence tools as medical devices.
Scholar highlights the fragmented regulatory environment governing advanced neurological technology.
Using artificial intelligence in public consultation processes could enhance participation in rulemaking.
Organizations should tailor contract requirements for procured AI systems based on levels of risk.
Measurement modeling could further the government’s understanding of AI policymaking tools.
Soft law standards can promote responsible procurement of artificial intelligence systems.
Contracting officials and agency leaders are key to the deployment of ethical AI processes.
Developing ongoing programs to monitor AI and sustain good outcomes is essential to ensure AI accountability.
By using artificial intelligence, agencies can improve their procurement processes.